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Abstract
Limited information is available on the molecular mechanisms associated with Campylobacter jejuni (C. jejuni) induced food-
borne diarrheal illnesses. In this study, we investigated the function of TLR/NF-kB signaling in C. jejuni induced pathogenesis
using gnotobiotic IL-10
2/2; NF-kB
EGFP mice. In vitro analysis showed that C. jejuni induced IkB phosphorylation, followed by
enhanced NF-kB transcriptional activity and increased IL-6, MIP-2a and NOD2 mRNA accumulation in infected-mouse
colonic epithelial cells CMT93. Importantly, these events were blocked by molecular delivery of an IkB inhibitor (Ad5IkBAA).
NF-kB signalling was also important for C.jejuni-induced cytokine gene expression in bone marrow-derived dendritic cells.
Importantly, C. jejuni associated IL-10
2/2; NF-kB
EGFP mice developed mild (day 5) and severe (day 14) ulcerating colonic
inflammation and bloody diarrhea as assessed by colonoscopy and histological analysis. Macroscopic analysis showed
elevated EGFP expression indicating NF-kB activation throughout the colon of C. jejuni associated IL-10
2/2; NF-kB
EGFP mice,
while fluorescence microscopy revealed EGFP positive cells to be exclusively located in lamina propria mononuclear cells.
Pharmacological NF-kB inhibition using Bay 11-7085 did not ameliorate C. jejuni induced colonic inflammation. Our findings
indicate that C. jejuni induces rapid and severe intestinal inflammation in a susceptible host that correlates with enhanced
NF-kB activity from lamina propria immune cells.
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Introduction
The gram-negative Campylobacter jejuni (C. jejuni) is the most
prevalent cause of bacterial-food borne diarrheal diseases
worldwide with up to 2.4 million cases annually in the United
States alone [1]. This microorganism colonizes the cloaca, cecum
and large intestine of birds and the ileum and colon of humans.
The main sources of transmission to humans are the consumption
and handling of contaminated poultry, and to a lesser extent
ingestion of contaminated water [2–5]. Although poultry which
are frequently colonized with up to 10
10 C. jejuni bacteria/g of
cecal content remain healthy, infected humans develop gastroen-
teritis with as few as 100–500 C.jejuni (strain 81–176) [6]. Clinical
features of C. jejuni infection range from severe inflammatory
bloody diarrhea to mild non-inflammatory watery diarrhea
accompanied by acute abdominal pain and fever, which lasts
between 24–48 h and generally resolves after 10 days [5].
Although the infection is self limiting in healthy persons, reactive
arthritis, gastrointestinal (reactivation of inflammatory bowel
diseases) and neurological (Guillian-Barre ´-Syndrome) disorders
have been reported in susceptible hosts [3]. C. jejuni is a
microaerophilic, motile Gram negative invasive bacterium from
the family Campylobacteraceae that possesses a single polar
flagellum at one or both ends [7]. Although the rate of C. jejuni
infection exceeds that of salmonellosis and shigellosis, a paucity of
information exists on the pathogenesis and host response to this
microorganism [8–11]. This is likely due to the lack of reliable
experimental murine models reproducing various aspects of C.
jejuni pathogenesis [11]. Murine models of C.jejuni infection are
typically viewed as colonization rather than disease models,
thereby limiting the generation of new knowledge regarding host
responses to this pathogen [11–14].
Recent reports utilizing new genetically deficient mice have shed
light on C. jejuni-induced pathogenesis. For example, Muc-1
2/2
mice are more susceptible to C. jejuni colonization and displayed
small intestinal epithelial damage [15]. This indicates that
production of the mucin layer represents an important host innate
protective mechanism against C. jejuni-mediated pathogenesis.
Subsequent reports identified the antimicrobial Nramp1 protein
as an important regulator of C. jejuni-induced pathogenesis
[13,16,17]. Mice deficient for both the TLR signaling protein
MyD88 and the antimicrobial protein Nramp1 were more
susceptible to C. jejuni colonization when administered systemically.
Although useful, these new findings provide limited insight into the
inflammatory host response to C. jejuni infection and ensuing
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7413diarrhea/inflammation.However,tworecentreportshaveprovided
a potential new model to study C. jejuni-induced colitis. Using IL-
10
2/2 mice housed in specific pathogen free (SPF) conditions,
Mansfield and colleagues demonstrated that enteritis developed in
,50–80%of C. jejuni (NCTC 11168) colonized IL-10
2/2 miceafter
more than 28 days of infection depending on the genetic
background [18,19]. Fairly high doses of inoculum (10
6–10
10
colony forming units (cfu)) were necessary to achieve colonization
and inflammatory response in this model. Nevertheless, these
findings indicate that C. jejuni colonizes the intestinal tract of murine
hosts exhibiting defective innate or immunoregulatory responses.
Despite the important progress made using these new models, the
molecular mechanism responsible for C. jejuni-mediated pathogen-
esis remains largelyelusive. Inthisstudy,weutilizeaninvitroandin
vivo approach to dissect the function of TLR/NF-kB signaling in C.
jejuni-induced pathogenesis.
Materials and Methods
Ethics statement
All animal protocols were approved by the Institutional Animal
Care and Use Committee of the University of North Carolina at
Chapel Hill.
Mice
Germ-free IL-10
wt/wt;N F ˜kB
EGFP, IL-10
2/2; NF-kB
EGFP (129/
SvEv;C57/Bl/6 mixed background) mice [20] and IL-10
2/2 and
WT (129/SvEv) mice were associated with various doses of C. jejuni
(Strain 81–176; 10
2,1 0
4,1 0
6, and 10
8 cfu/mouse). Mice were
sacrificed at 14 days. Mice were housed under germ-free
conditions at the Gnotobiotic Animal Facility at the University
of North Carolina at Chapel Hill and associated with 10
8
cfu/mouse. Mice were sacrificed after 14 days. Mice were
monitored weekly for C. jejuni association with PCR or stool
culture using the following primer pair: TGTTGAAGGGTTT-
GAAGAGC (forward), GCAAGTTGACCCTCTTCTATGG
(reverse). In addition, C. jejuni association and absence of
contamination by other bacterial species were confirmed by
periodic culture of stool samples. For inhibition of NF-kB in vivo,
mice were treated with Bay 11–7085 (Calbiochem, La Jolla, CA)
i.p. (200 mg/kg) one day before C. jejuni association and then
injected three times per week. After completion of the experiment,
mice were euthanized with CO2 intoxication. Proximal and distal
colon, cecum, small intestine, mesenteric lymph nodes (MLN),
spleen and liver were collected from each mouse and used for
further processing of RNA, protein and tissue cultures on regular
agar plates (Mueller Hinton Agar, Remel, Lenexa, KS) or on
Brucella Agar plates (Remel) over 24–48 h. Proximal and distal
colon as well as cecum and small intestine were fixed in 10%
buffered formalin (Fisher Scientific, Pittsburgh, PA, USA)
overnight, paraffin-embedded, sectioned, and stained with H&E
for histological evaluation. Histological assessment was performed
by two blinded investigators using a score as described previously
[21]. Briefly, mucosal inflammation was scored by evaluation of
the degree of lamina propria mononuclear cell infiltration, loss of
goblet cells, architectural distortion as well as crypt hyperplasia
using a score from 0–4.
C. jejuni preparation
C. jejuni strain 81–176 (human isolate) was grown under
microaerophilic conditions on regular agar plates over 24–
48 hours using a MACS VA 500 microaerophilic workstation
(Don Whitley Scientific, Microbiology International, Frederick,
MD). The bacteria were resuspended in Tryptic Soy Broth
(Teknova, Hollister, CA), counted and diluted to a final
concentration ranging between 10
2,1 0
4,1 0
6,1 0
8 and 10
9 cfu/ml.
Each culture was gram stained (Fisher Scientific) and checked
for pure culture conditions under the microscope for each
experiment.
Cell lines
The immortalized murine rectum carcinoma cell line CMT-93
was cultured as described previously [22]. Cells were incubated
with C.jejuni (moi 50) in 1% medium for different time points.
Supernatant and cells were collected for further analysis in 1X
Laemmli-buffer for protein analysis and Trizol (Invitrogen,
Carlsbad, CA) for RNA analysis.
RNA extraction and amplification by RT-PCR
RNA was isolated using TRIzol (Invitrogen), reverse transcribed
and amplified as previously described using primers specific for
murine MIP-2, IL-12p40, TNFa, IL-6, and GAPDH [20,23]. For
PCR analysis, products were subjected to electrophoresis on 2%
agarose gels containing GelStar fluorescent dye (Cambrex
BioScience Rockland). Fluorescence staining was captured using
an Alpha Imager 2000 (Alpha Innotech, San Leandro, CA).
Cytokine expression was quantified using real-time PCR (Applied
Biosystems 7900HT Fast Real-Time PCR System). Primer
sequences were as follows;
Western blot
Proteins were separated using SDS-PAGE and transferred to
nitrocellulose membranes. Antibodies to IkBa and RelA were
diluted 1:1000 in 0.1% TBS-Tween with 5% dry milk.
Immunoreactive proteins were detected using the enhanced
chemiluminescence light (ECL) detecting kit (Amersham Biosci-
ences, Piscataway, NJ) as described previously [23].
Adenoviruses and cell infection
CMT-93 cells were infected with the adenoviral vector
Ad5IkBAA in serum-reduced media (1%) at optimal multiplicity
of infection (MOI) for 12 hr. The adenovirus was washed off, fresh
serum-reduced medium was added and cells were stimulated with
C. jejuni (moi 50) and LPS (5 mg/ml). Cells were pretreated
with cyclohexamide (CHX, 50 mg/ml Sigma) to prevent IkB
resynthesis.
Assessment of enhanced EGFP expression
NF-kB
EGFP, IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP
mice were sacrificed at the indicated times and the entire colon
GATCTTCATGAGGTAGTCTGT b-actin reverse
CCAACCGTGAAAAGATGACC b-actin forward
GGTGAAGGTCGGTGTGAACGGA GAPDH forward
GTGGGGTCTCGCTCCTGGAAGA GAPDH reverse
CGGAGGCTTGGTTACACATGTT IL-6 forward
CTGGCTTTGTCTTTCTTGTTATC IL-6 reverse
TACAGGCTTGTCACTCGAATT TNFa forward
ATGAGCACAGAAAGCATGATG TNFa reverse
CACGGCAGCAGAATAAATATG IL-12p40 forward
TTGCATTGGACTTCGGTAGA IL-12p40 reverse
CCGCTGTTGTGGCCAGTGAACTGCG MIP-2 forward
TTAGCCTTGCCTTTGTTCAGTAT MIP-2 reverse
C. jejuni-Induced Colitis
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described previously [20]. For tissue sections, colons were resected
from mice following infection as described in the text, fixed in 4%
paraformaldehyde (PFA) for 10–24 hours, washed twice in PBS,
and transferred to vials containing 30% sucrose for 24 hours. Five
to seven micron (mm) sections were cut on a cryostat and counter-
stained with DAPI. EGFP expression was imaged using an
Olympus IX70 (Olympus, Melville, NY) fitted with EGFP-specific
filters (Omega Optical, XF116-2, Brattleboro, VT). Images were
captured using a digital SPOT
TM camera (Diagnostic Instruments
Inc., McHenry, IL). Identical exposure times were used for each
data point within an individual experiment.
Colonoscopy
Direct visualization of the colon in vivo was performed using a
‘‘Coloview system’’ (Karl Storz Veterinary Endoscopy). Mice were
supplied with food and water until the endoscopy was performed.
If fecal material obstructed the view of the endoscope, colons were
flushed with 0.9% saline. For the colonoscopies, mice were
anesthetized with 1.5 to 2% isoflurane and 3 to 4 cm of the colon
from the anal verge until the splenic flexure was visualized after
inflation of the colon with air. The colonoscopic procedures were
digitally recorded on an AIDA Compaq PC.
Statistical analysis
Data are expressed as mean +/2 standard deviation. Statistical
analysis was performed using the Mann-Whitney test (histology)
and students t-test (remaining data) and using SigmaPlot for
Windows Version 8.0 and SigmaStat for Windows Version 3.5.
The t-test was used to investigate whether the means of two groups
are statistically different from each other. This analysis is
appropriate whenever one wants to compare the means of two
groups. The Mann-Whitney test was used as a non-parametric test
for assessing whether two independent samples of observations
Figure 1. C. jejuni induces NF-kB-signalling and gene expression in CMT-93 cells. (A) C. jejuni infection induced IkB degradation in CMT93
cells. Cells were infected with C. jejuni (MOI 50) for the indicated time points in presence or absence of cycloheximide (CHX; 25 mg/ml). Total protein
was extracted and 20 mg was subjected to SDS-PAGE followed by immunoblotting with IkBa and RelA specific antibodies. (B) C. jejuni infection
induced NF-kB transcriptional activity in CMT93 cells. CMT-93 cells were infected with the reporter Ad5NF-kB-LUC adenoviral vector and where
indicated co-infected with Ad5IkBAA (MOI: 50) to block the kB-luciferase activity. Cells were then infected with C. jejuni (MOI 50) for 24 h and
luciferase activity measured after 16 h using an Lmax microplate reader. Results were normalized for extract protein concentrations (*p=0.008
control vs. C. jejuni infected cells; p=0.013 C. jejuni vs. C. jejuni-Ad5IkBAA). (C) Increased IL-6, MIP-2 and NOD2 mRNA accumulation in C. jejuni
infected CMT93 cells. CMT-93 cells were infected with Ad5IkBAA and then stimulated with LPS (5 mg/ml) or infected with C. jejuni (MOI 50) for the
indicated time points. Cells were lysed in trizol, and total RNA was extracted, reverse-transcribed (1 mg), and amplified by PCR using specific murine
IL-6, MIP-2 and NOD2 primers. The housekeeping gene GAPDH was utilized to ascertain similar loading. Results are representative of 3 independent
experiments.
doi:10.1371/journal.pone.0007413.g001
C. jejuni-Induced Colitis
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significant with a p-value of ,0.05.
Results
C. jejuni induces NF-kB-signaling and gene expression in
intestinal epithelial cells and in bone marrow-derived
dendritic cells (BMDC)
We first investigated the impact of NF-kB signaling on C. jejuni
mediated host response using the murine colonic cell line CMT-
93. As seen in Fig. 1A, C. jejuni (MOI 10) time-dependently
induced IkBa degradation as measured by Western blot analysis, a
process better appreciated when cells were exposed to the protein
synthesis inhibitor cyclohexamide (CHX). In addition, NF-kB
transcriptional activity significantly increased (.6 fold) in C. jejuni-
infected CMT93 cells (Fig. 1B). Importantly, the IkB super-
repressor delivered by adenoviral vector (Ad5IkBAA) significantly
reduced C. jejuni-induced NF-kB transcriptional activity in CMT-
93 cells (Fig. 1B). To investigate the impact of NF-kB signaling on
C. jejuni-induced endogenous gene expression, we next measured
IL-6, MIP-2 and NOD2 mRNA accumulation in cells expressing
the IkB super-repressor. Interestingly, C. jejuni–induced IL-6 and
MIP-2 mRNA accumulation was strongly blocked by Ad5IkBAA
(Fig. 1C).
Activation of TLR signalling by antigen presenting cells such
as dendritic cells plays a key role in the innate host response to
invasive pathogenic bacteria. We next investigated the role of
NF-kB signalling in C.jejuni induced host response in BMDC
generated from WT mice using the pharmacological inhibitor
Bay 11-7085. Fig. 2 showed that C.jejuni-induced IL-12p40
(Fig. 2A) and IL-6 (Fig. 2B) mRNA accumulation was strongly
reduced in Bay 11-7085-treated BMDC compared to untreated
cells. In summary, C. jejuni infection induces the classical NF-kB
activation pathway in vitro, leading to increased expression of
NF-kB dependent genes in mouse colonic epithelial CMT-93
cells and in BMDC.
C. jejuni-mono associated IL-10
2/2; NF-kB
EGFP mice
display rapid, severe and progressive colonic
inflammation
We previously reported that gnotobiotic IL-10
2/2 mice
represent a powerful tool to study host response to commensal
bacteria colonization [20]. Germ-free IL-10
2/2; NF-kB
EGFP mice
and control IL-10
wt/wt; NF-kB
EGFP mice were associated with C.
jejuni by oral gavage (10
8 cfu/mouse) and inflammation was
evaluated macroscopically after 5 and 14 days using a murine
miniature endoscope. Interestingly, C. jejuni induces rapid and
progressive severe, ulcerating colonic inflammation with bloody
diarrhea in IL-10
2/2; NF-kB
EGFP mice (Fig. 3B), whereas IL-
10
wt/wt; NF-kB
EGFP control mice demonstrate macroscopically
Figure 2. NF-kB signaling drives C. jejuni induced cytokine gene
expression in BMDC. BMDC were generated from WT mice and
treated with Bay 11-7085 (10 mM) and then stimulated with C. jejuni
(MOI 50) for 4 h. Cells were lysed in Trizol, total RNA was extracted,
reverse transcribed and IL-12p40 (A) and IL-6 (B) mRNA expression was
detected using real-time PCR (Applied Biosystems 7700 sequence
detection system). Results were normalized to the housekeeping gene
GAPDH to ascertain similar loading. Results are the mean +/2 SD of
triplicates samples and are from one of three independent experiments
(*p=0.011 for IL-12p40 vs. Bay 11-7085-treated cells; *p=0.005 for IL-6
vs. Bay 11-7085-treated cells).
doi:10.1371/journal.pone.0007413.g002
Figure 3. C. jejuni induces rapid and progressive severe colonic
inflammation in IL-10
2/2; NF-kB
EGFP mice. Gnotobiotic IL-10
2/2;
NF-kB
EGFP mice and control IL-10
wt/wt; NF-kB
EGFP mice were associated
with C. jejuni by oral gavage (10
8 cfu/mouse). Inflammation was
evaluated macroscopically in vivo using a murine miniature endoscope
in IL-10
wt/wt; NF-kB
EGFP control mice (Fig. 2A, n=13) and IL-10
2/2; NF-
kB
EGFP mice on day 5 and 14 (Fig. 2B, n=12). The data are
representative for two additional experiments.
doi:10.1371/journal.pone.0007413.g003
C. jejuni-Induced Colitis
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assessment of C. jejuni induced colonic inflammation, colons of 14-
day C. jejuni associated IL-10
2/2; NF-kB
EGFP and IL-10
wt/wt; NF-
kB
EGFP mice were dissected, fixed and sectioned for histological
analysis. As expected, C. jejuni-associated IL-10
2/2; NF-kB
EGFP
mice showed strong signs of inflammation in the cecum, proximal
and distal colon whereas C. jejuni associated IL-10
wt/wt; NF-kB
EGFP
mice displayed minimal inflammation (Fig. 4A). Representative
histological sections from C. jejuni-associated IL-10
2/2; NF-
kB
EGFP mice showed clear signs of inflammation after 14 days
with crypt hyperplasia, goblet cell depletion, immune cell
infiltration and ulcers. IL-10
wt/wt; NF-kB
EGFP mice displayed
normal physiologic cell structure (Fig. 4B). Polymerase chain
reaction (PCR) as well as serial bacterial cultures performed in
sterilely harvested stool samples confirmed the presence of viable
C. jejuni in both IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP
mice 14 days after association, indicating that both gnotobiotic IL-
10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP mice are colo-
nized by this microorganism (data not shown).
To gain more insight into the signalling event associated with C.
jejuni induced colitis, IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-
kB
EGFP mice were colonized for 14 days and their colons dissected
and EGFP expression visualized using a CCD camera in a light-
tight imaging box with a dual filtered light source. C. jejuni
associated IL-10
2/2; NF-kB
EGFP mice exhibited enhanced EGFP
expression (NF-kB activity) over the entire length of the colon as
compared to IL-10
wt/wt; NF-kB
EGFP mice (Fig. 5A). Western blot
analysis of whole colon protein extracts showed elevated EGFP
expression in C. jejuni-associated IL-10
2/2; NF-kB
EGFP compared
to IL-10
wt/wt; NF-kB
EGFP mice (Fig. 5B). To further define cell
types responsible for the overall macroscopic increase in EGFP
expression, colonic sections from 14-day C. jejuni associated IL-
10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP mice were
examined. Of note, C. jejuni induced EGFP expression was mostly
confined to lamina propria mononuclear cells located in-between
the crypts in IL-10
2/2; NF-kB
EGFP mice whereas EGFP
expression was minimal in IL-10
wt/wt; NF-kB
EGFP mice (Fig. 6).
In accordance with enhanced NF-kB activity (EGFP expression),
Figure 4. Histology showed strong signs of inflammation in IL-10
2/2; NF-kB
EGFP mice. Gnotobiotic IL-10
2/2; NF-kB
EGFP mice were
associated with C. jejuni by oral gavage (10
8 cfu/mouse) for 14 days. Mice were euthanized and different parts of the colon were paraffin-embedded
and used for H&E staining. Histological analysis of C. jejuni-associated IL-10
2/2; NF-kB
EGFP and IL-10
wt/wt; NF-kB
EGFP was performed as described in
Materials and Methods. Histological score revealed statistical significant difference between IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP associated
with C. jejuni (cecum *p=0.003, prox *p=0.004, dist *p=0.003). IL-10
wt/wt; NF-kB
EGFP: n=8, IL-10
2/2; NF-kB
EGFP: n=4, IL-10
wt/wt; NF-kB
EGFP C. jejuni
associated: n=13, IL-10
2/2; NF-kB
EGFP C. jejuni associated: n=12. WT=IL-10
wt/wt; NF-kB
EGFP, KO=IL-10
2/2; NF-kB
EGFP.
doi:10.1371/journal.pone.0007413.g004
C. jejuni-Induced Colitis
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was detected in C. jejuni-associated IL-10
2/2; NF-kB
EGFP mice
compared to IL-10
wt/wt; NF-kB
EGFP mice (Fig. 7). Although
asymptomatic, increased TNF and IL-12p40 mRNA accumula-
tion was observed in C. jejuni-associated IL-10
wt/wt; NF-kB
EGFP
mice compared to germ-free mice.
We next tested the sensitivity of our infection protocol in
gnotobiotic IL-10
2/2 mice. Germ-free mice were infected with
different C. jejuni amounts (10
2,1 0
4, and 10
6 cfu/mouse) for 14
days and the degree of intestinal inflammation was determined by
histological analysis (Fig. 8A). Interestingly, the intestine of IL-
10
2/2 mice infected with as low as 10
2 bacterium displayed loss of
architecture, loss of goblet cells, immune cell infiltration and
epithelial hyperplasia in the cecum, proximal and distal colon,
indicating that germ-free IL-10
2/2 mice are exquisitely sensitive
to C. jejuni infection (Fig. 8B). These findings demonstrate that
germ-free IL-10
2/2 mice develop rapid and severe intestinal
inflammation following C. jejuni infection, which correlates with
activation of NF-kB signalling.
To further definethe roleof NF-kB signalling in the development
of C.jejuni-induced colitis, NF-kB activation was pharmacologically
inhibited in gnotobiotic IL-10
2/2; NF-kB
EGFP mice using Bay 11-
7085 (200 mg/kg i.p.; 3 injections per week for 14 days).
Interestingly, although we previously showed that Bay 11-7085
attenuated commensal bacteria-induced colitis in IL-10
2/2 mice,
histological analysis showed that C. jejuni-induced colitis still
developed in mice treated with the NF-kB inhibitor (data not
shown).
Discussion
In this study, we define host responses to C. jejuni infection using
gnotobiotic technology. Since the transcription factor NF-kBi sa
key component of host responses to various infectious microor-
ganisms, we focused our attention on the pattern of NF-kB activity
using IL-10
2/2; NF-kB
EGFP mice. C. jejuni mono-associated IL-
10
2/2 mice developed rapid and severe colitis, even in the
presence of low bacterial inoculum (10
2 cfu/mouse). This finding
shows that C jejuni itself has the capacity of inducing disease and
that the contribution of other intestinal microorganisms is likely
not needed. Another important observation is the difference of
disease onset between gnotobiotic IL-10
2/2; NF-kB
EGFP mice (14
days, severe bloody inflammation) and mice housed in regular
specific pathogen free conditions (.30 days, mild inflammation)
Figure 5. C. jejuni induces NF-kB signaling in IL-10
2/2; NF-kB
EGFP mice. (A) C. jejuni induces NF-kB activity in the colon of IL-10
2/2; NF-kB
EGFP
mice. IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP mice were colonized for 14 days with C. jejuni (10
8 cfu/mouse), mice were euthanized, colons
dissected and EGFP expression immediately visualized using a CCD camera in a light-tight imaging box with a dual filtered light source. The data are
representative of three independent experiments. IL-10
wt/wt; NF-kB
EGFP: n=8, IL-10
2/2; NF-kB
EGFP: n=4, IL-10
wt/wt; NF-kB
EGFP C. jejuni associated:
n=13, IL-10
2/2; NF-kB
EGFP C. jejuni associated: n=12. (B) C. jejuni induces elevated EGFP protein expression in the colon. Colonic protein of C. jejuni
associated IL-10
wt/wt; NF-kB
EGFPand IL-10
2/2; NF-kB
EGFP were extracted and 20 mg were used for SDS-PAGE gel analysis. Gels were stained with EGFP
specific antibodies. n=3 per group.
doi:10.1371/journal.pone.0007413.g005
C. jejuni-Induced Colitis
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establish a niche in germ free mice whereas the complex intestinal
microbiota present in SPF conditions severely restrain C. jejuni
expansion/colonization.
Although IL-10
2/2 mice are susceptible to bacterial infection/
colonization, it is important to underline the selective nature of
their host responses to various bacterial strains. For example,
Helicobacter hepaticus, a potential pathogenic microorganism that has
been reported to induce colitis, hepatitis, and hepatocellular
carcinoma in numerous murine models including A/JCr, SCID/
NCr and RAG-2
2/2 mice failed to induce colitis or to potentiate
colitis in conventionalized IL-10
2/2 mice [24]. Also, the gram-
negative Bacteroides vulgatus bacterium fails to trigger significant
inflammation in IL-10
2/2 mice [21] whereas the same organism
triggers severe colitis in HLA-B27/b2 microglobulin transgenic
rats [25]. Moreover, we recently showed that in a model of colitis-
associated colon cancer, B. vulgatus failed to promote tumor
development in IL-10
2/2 mice whereas numerous adenomas are
present in conventionalized- IL-10
2/2 mice [26]. In addition to
the differential impact of bacteria on colitis in IL-10
2/2 mice, the
onset of disease is also selectively modulated by colitogenic
bacteria. For example, Enterococcus faecalis induced a slow-onset
(10–12 weeks) of distal colon predominant inflammation, which
progressed to severe distal colitis and duodenal inflammation by
24 weeks in IL-10
2/2 mice [27]. As opposed, Escherichia coli-
monoassociated IL-10
2/2 mice developed moderate to severe
disease by 16 weeks [27]. In all of the above gnotobiotic
experiments with colitogenic bacteria, none of the mice developed
rectal bleeding or bloody diarrhea. These findings clearly illustrate
the selective nature of IL-10
2/2 mice host responses to microbial
colonization/infection. In essence, not all bacterial strains induce
intestinal inflammation in this model and the onset/location of
inflammation is often bacterial strain specific. The key feature of
our gnotobiotic IL-10
2/2 model is the rapidity by which C. jejuni
promotes intestinal inflammation. C. jejuni monoassociated IL-
10
2/2 mice developed moderate (5 days) to severe (14 days)
intestinal inflammation (cecal, proximal and distal colon) accom-
panied with bloody diarrhea, an onset never observed with any
non-pathogenic bacterial strains utilized in the laboratory so far.
These findings indicate that C. jejuni responses in IL-10
2/2 mice
are unique to the biology of the microorganism and are not
reproduced by other commensal/pathogenic bacteria studied so
far in this model (E. coli, E. feacalis, H. hepaticus, B. vulgatus or P.
fluorescens). Consequently, gnotobiotic IL-10
2/2 mice may repre-
Figure 6. EGFP expression is predominantly found in lamina propria mononuclear cells of C. jejuni-infected IL-10
2/2; NF-kB
EGFP
mice. Colonic sections from 14 days C. jejuni associated IL-10
wt/wt; NF-kB
EGFP and IL-10
2/2; NF-kB
EGFP mice were examined by fluorescent
microscopy. The localization of EGFP positive cells was determined by simultaneous EGFP and DAPI analysis.
doi:10.1371/journal.pone.0007413.g006
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response mechanisms intrinsically associated with C. jejuni
pathogenesis. Some of the pathways may be clinically relevant
but more investigation will be needed to confirm their roles.
Toll-like receptor (TLR) and nucleotide-binding oligomeriza-
tion domain (Nod) proteins are essential signaling pathways
involved in innate/adaptive host responses to various commensal
and pathogenic bacteria [28]. For example, TLR4 detects the
presence of extracellular bacterial products (LPS), whereas NOD2
senses peptidoglycan and its by-product muramyldipeptide (MDP).
In addition, NOD2 senses live intracellular pathogenic microor-
ganisms such as Salmonella enterica, Listeria monocytogenes, Mycobacte-
rium tuberculosis and Streptococcus pneumoniae [29–32]. This host
response is central to the elimination of the damaging agents and
to the reestablishment of homeostasis. For example, defective
Nod2 signalling impaired Salmonella typhimurium clearance by
intestinal epithelial cells in vitro and decreased host responses to
Listeria monocytogenes infection in vivo [30,31]. Similarly, defective
TLR/MyD88 signalling enhanced host susceptibility to Mycobac-
terium avium, Citrobacter rodentium, C. jejuni infection and S. typhimurium
clearance [33–35]. Interestingly, we observed a strong induction of
NOD2 mRNA in C. jejuni infected CMT-93 cells suggesting a
potential role for this innate sensor in controlling infection.
However, preliminary studies showed that similar to WT,
NOD2
2/2 mice housed in SPF conditions failed to develop colitis
following C. jejuni infection (data not shown). This finding suggests
that this innate sensor is not critical for host response to C. jejuni
and that other signalling pathways may be at play in this model.
An important TLR/NOD down-stream effecter target is the
NF-kB transcriptional system, which controls the expression of
numerous genes involved in both innate and adaptive responses.
We recently demonstrated that TLR/MyD88 signalling to the NF-
kB transcriptional system is critical for commensal bacteria-
induced colitis in IL-10
2/2 mice [20,36]. Interestingly, mice
partially deficient for NF-kB activation (p50
2/2;p65
+/2) exhibit
evidence of C. jejuni-induced gastroenteritis whereas wild-type mice
remain healthy [14]. These findings together with our results
suggest that activation of NF-kB dependent genes may be an
important feature of host responses to C. jejuni infection. However,
because p50
2/2;p65
+/2 mice still have a functional p65 allele and
are therefore capable of inducing a subset of NF-kB dependent
genes, the relationship between this transcription factor and C.
jejuni-induced disease remains to be defined.
We show that C. jejuni induced MIP-2, IL-6, TNF and IL-
12p40 gene expression was dependent on activation of NF-kB
signalling in murine colonic CMT-93 cell line and BMDC.
Moreover, a strong increase in colonic EGFP expression was
observed in C. jejuni-infected IL-10
2/2;N F - kB
EGFP mice
compared to IL-10
wt/wt;N F - kB
EGFP mice. Surprisingly, phar-
macological NF-kB inhibition using Bay 11-7085 failed to
prevent C. jejuni-induced colitis. This is in sharp contrast with
t h es a m eN F - kB inhibitor attenuating E. faecalis/E. coli-induced
EGFP expression and development of colitis in IL-10
2/2 mice
[20]. Given the extent of NF-kB activation in our model, one
could predict that blocking NF-kB activity would either
exacerbate or attenuate C. jejuni-induced colitis. One possible
explanation for the lack of clear effect is that C.jejuni-induced NF-
kB activity initiates both protective and deleterious host
responses in this model. For example, intestinal-derived NF-kB
signalling may be important for the induction of antimicrobial
factors and to maintain proper barrier function in response to C.
jejuni infection. On the other hand, production of NF-kB-
dependent inflammatory mediators by lamina propria immune
cells may be part of the inflammatory process observed in C.
jejuni-infected mice. The net effect of NF-kB inhibition on C. jejuni
pathogenesis is likely to be the sum of both of these positive and
negative forces. One would need to use mice with tissue specific
deletion of key NF-kB signaling molecules to tease out the
contribution of this transcription factor on C. jejuni-induced
pathogenesis. In summary, using gnotobiotic IL-10
2/2;N F -
kB
EGFP mice, we show that C. jejuni triggers rapid and severe
intestinal inflammation accom p a n i e db yb l o o d yd i a r r h e a .
Although C. jejuni infection leads to activation of NF-kBb o t hi n
vitro and in vivo, blockade experiments failed to clearly assess the
contribution of this transcription factor in C. jejuni-induced
pathogenesis. Experiments using mice with intestinal-specific
deletion of I kappa b kinase b (IKKb)o nt h eb a c k g r o u n do fI L -
10
2/2 mice are currently underway and should help determine
t h er o l eo fN F - kBo nC. jejuni-induced pathogenesis.
Figure 7. Increased TNFa and IL-12p40 mRNA accumulation in
C. jejuni-associated IL-10
2/2; NF-kB
EGFP mice. IL-10
wt/wt; NF-kB
EGFP
and IL-10
2/2; NF-kB
EGFP were associated with C. jejuni for 14 days.
Colonic sections were lysed in trizol and RNA was extracted, reverse-
transcribed (1 mg) and amplified by PCR using specific murine TNFa and
IL12p40 primers. GAPDH was used as loading control. WT=IL-10
wt/wt;
NF-kB
EGFP, n=7; KO=IL-10
2/2; NF-kB
EGFP,n=7 ;W TC. jejuni associated:
n=12; KO C. jejuni associated: n=10. (*p=0.002 for IL12p40 vs. control,
*p=0.001 for TNF vs. control).
doi:10.1371/journal.pone.0007413.g007
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